المؤلفون: Zhai C; Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Road, Huaiyin District, 250021, Jinan, Shandong, China., Wang F; Department of Infection Management, Weishan People's Hospital, No. 10 Chenghou Road, Xiazhen Street, Weishan County, 277600, Jining, Shandong, China., Xu R; Department of Respiratory, Heze Municipal Hospital, No. 2888 Caozou, Mudan District, 274031, Heze, Shandong, China., Sun X; Department of Geriatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Road, Huaiyin District, 250021, Jinan, Shandong, China., Ma W; School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, No. 1166 Liutai Avenue, Wenjiang District, 611137, Chengdu, Sichuan, China., Wang L; Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324 Jingwu Road, Huaiyin District, 250021, Jinan, Shandong, China.

المصدر: Postgraduate medical journal [Postgrad Med J] 2024 Sep 22; Vol. 100 (1188), pp. 721-729.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0234135 Publication Model: Print Cited Medium: Internet ISSN: 1469-0756 (Electronic) Linking ISSN: 00325473 NLM ISO Abbreviation: Postgrad Med J Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/drug therapy , Benzyl Alcohols*/therapeutic use , Benzyl Alcohols*/administration & dosage , Chlorobenzenes*/therapeutic use , Chlorobenzenes*/administration & dosage , Quinuclidines*/therapeutic use , Randomized Controlled Trials as Topic* , Bronchodilator Agents*/therapeutic use , Fluticasone-Salmeterol Drug Combination*/therapeutic use, Humans ; Muscarinic Antagonists/therapeutic use ; Muscarinic Antagonists/administration & dosage ; Drug Combinations ; Administration, Inhalation ; Forced Expiratory Volume/drug effects ; Quality of Life ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Adrenergic beta-2 Receptor Agonists/administration & dosage

المؤلفون: Song Y; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China., Huang Q; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China., Pu Q; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China., Ni S; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China., Zhu W; Department of Anaesthesiology, Huashan Hospital, Fudan University, Shanghai 200040, China., Zhao W; Department of Anaesthesiology, Huashan Hospital, Fudan University, Shanghai 200040, China., Xu H; Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.; National Center for Neurological Disorders, Shanghai 200040, China.; Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai 200040, China.; Neurosurgical Institute, Fudan University, Shanghai 200040, China.; Shanghai Clinical Medical Center of Neurosurgery, Shanghai 200040, China., Hu K; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

المصدر: Bioconjugate chemistry [Bioconjug Chem] 2024 Sep 18; Vol. 35 (9), pp. 1380-1390. Date of Electronic Publication: 2024 Aug 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4812 (Electronic) Linking ISSN: 10431802 NLM ISO Abbreviation: Bioconjug Chem Subsets: MEDLINE

مواضيع طبية MeSH: Temozolomide*/pharmacology , Temozolomide*/therapeutic use , Glucosides*/pharmacology , Glucosides*/chemistry , Glucosides*/therapeutic use , Liposomes*/chemistry , Astrocytes*/drug effects , Astrocytes*/metabolism , Benzyl Alcohols*/pharmacology , Benzyl Alcohols*/chemistry , Benzyl Alcohols*/therapeutic use , Down-Regulation*/drug effects , Connexin 43*/metabolism, Animals ; Mice ; Cell Line, Tumor ; Humans ; Glioma/drug therapy ; Glioma/pathology ; Glioma/metabolism ; Glioblastoma/drug therapy ; Glioblastoma/pathology ; Glioblastoma/metabolism ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use ; Brain Neoplasms/drug therapy ; Brain Neoplasms/pathology ; Brain Neoplasms/metabolism ; Mice, Inbred C57BL

المؤلفون: Dai Y; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China., Ban W; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China., Yang Z; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 02; Vol. 25 (17). Date of Electronic Publication: 2024 Sep 02.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Benzyl Alcohols*/pharmacokinetics , Benzyl Alcohols*/therapeutic use , Benzyl Alcohols*/pharmacology , Benzyl Alcohols*/chemistry , Glucosides*/pharmacokinetics , Glucosides*/therapeutic use , Glucosides*/chemistry , Glucosides*/pharmacology , Central Nervous System Diseases*/drug therapy , Central Nervous System Diseases*/metabolism, Humans ; Animals ; Gastrodia/chemistry

المؤلفون: Oppenheimer J; Rutgers New Jersey Medical School, Newark, NJ., Kerstjens HA; Faculty of Medical Sciences, University of Groningen and University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, the Netherlands., Boulet LP; Department of Medicine, Laval University, Quebec, QC., Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX., Kerwin E; Altitude Clinical Consulting and Clinical Research Institute, Medford, OR., Moore A; Global Medical Affairs, General Medicines, GSK, Brentford, Middlesex, UK., Nathan RA; Asthma & Allergy Associates, PC, and Research Center, Colorado Springs, Colo., Peachey G; Global Medical Affairs, General Medicines, GSK, Brentford, Middlesex, UK., Pizzichini E; Global Medical Affairs, General Medicines, GSK, Brentford, Middlesex, UK; Department of Clinical Medicine, Federal University of Santa Catarina, Santa Catarina, Brazil., Slade D; US Medical Affairs, GSK, Collegeville, PA., Zarankaite A; Global Medical Affairs, General Medicines, GSK, Brentford, Middlesex, UK., Pavord ID; Respiratory Medicine Unit and Oxford Respiratory National Institute for Health & Care Research Biomedical Research Centres, Oxford, UK. Electronic address: ian.pavord@ndm.ox.ac.uk.

المصدر: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 Sep; Vol. 12 (9), pp. 2372-2380.e5. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Asthma*/drug therapy , Asthma*/physiopathology , Benzyl Alcohols*/therapeutic use , Benzyl Alcohols*/administration & dosage , Chlorobenzenes*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Adult ; Severity of Illness Index ; Quinuclidines/therapeutic use ; Disease Progression ; Aged ; Androstadienes/therapeutic use ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Drug Combinations ; Anti-Asthmatic Agents/therapeutic use ; Administration, Inhalation ; Young Adult ; Treatment Outcome ; Adolescent ; Adrenal Cortex Hormones/therapeutic use

المؤلفون: Risebrough NA; ICON Global Health Economics and Outcomes Research, ICON plc, Toronto, ON, M2N 1A2, Canada. Electronic address: nancy.risebrough@iconplc.com., Mursleen S; Health Economics and Outcomes Research, GSK, Mississauga, ON, L5R 3G2, Canada. Electronic address: sara.x.mursleen@gsk.com., Ndirangu K; ICON Global Health Economics and Outcomes Research, ICON plc, New York, NY, 11735, USA. Electronic address: kgndirangu@gmail.com., Shah D; ICON Global Health Economics and Outcomes Research, ICON plc, New Jersey, NJ 07302, USA. Electronic address: dhvani.shah@iconplc.com., Martin A; Value Evidence and Outcomes, GSK, Brentford, TW8 9GS, UK. Electronic address: alan.a.martin@gsk.com., Schroeder M; Value Evidence and Outcomes, GSK, Brentford, TW8 9GS, UK. Electronic address: melanie.x.schroeder@viivhealthcare.com., Ismaila AS; Value Evidence and Outcomes, GSK, Collegeville, PA, 19426-0989, USA; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, L8S 4K1, Canada. Electronic address: afisi.s.ismaila@gsk.com.

المصدر: Respiratory medicine [Respir Med] 2024 Sep; Vol. 231, pp. 107694. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064 (Electronic) Linking ISSN: 09546111 NLM ISO Abbreviation: Respir Med Subsets: MEDLINE

مواضيع طبية MeSH: Pulmonary Disease, Chronic Obstructive*/drug therapy , Pulmonary Disease, Chronic Obstructive*/economics , Cost-Benefit Analysis* , Benzyl Alcohols*/economics , Benzyl Alcohols*/administration & dosage , Benzyl Alcohols*/therapeutic use , Quality-Adjusted Life Years* , Quinuclidines*/economics , Quinuclidines*/administration & dosage , Quinuclidines*/therapeutic use , Chlorobenzenes*/economics , Chlorobenzenes*/administration & dosage , Chlorobenzenes*/therapeutic use , Androstadienes*/economics , Androstadienes*/administration & dosage , Androstadienes*/therapeutic use, Humans ; Quebec ; Male ; Female ; Middle Aged ; Drug Combinations ; Nebulizers and Vaporizers/economics ; Administration, Inhalation ; Aged ; Pyrrolidines/economics ; Pyrrolidines/therapeutic use ; Pyrrolidines/administration & dosage ; Bronchodilator Agents/economics ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/therapeutic use ; Disease Progression ; Drug Therapy, Combination ; Treatment Outcome

المؤلفون: Huang WC; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan., Cheng WC; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan. wcchengdr@gmail.com.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan. wcchengdr@gmail.com.; Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan. wcchengdr@gmail.com.; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan. wcchengdr@gmail.com., Chen CY; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan., Liao WC; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan., Wu BR; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan.; Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan., Chen WC; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan.; Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan., Tu CY; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan., Chen CH; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan. hsnu758@gmail.com.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan. hsnu758@gmail.com., Hsu WH; Division of Pulmonary and Critical Care, Department of Internal Medicine, North District, China Medical University Hospital, No. 2, Yude Road, Taichung City, 40402, Taiwan.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.

المصدر: BMC pulmonary medicine [BMC Pulm Med] 2024 Aug 01; Vol. 24 (1), pp. 374. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article; Observational Study; Comparative Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE

مواضيع طبية MeSH: Benzyl Alcohols*/administration & dosage , Benzyl Alcohols*/therapeutic use , Asthma*/drug therapy , Chlorobenzenes*/administration & dosage , Chlorobenzenes*/therapeutic use , Drug Combinations*, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Adult ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/therapeutic use ; Administration, Inhalation ; Androstadienes/administration & dosage ; Androstadienes/therapeutic use ; Budesonide/administration & dosage ; Budesonide/therapeutic use ; Anti-Asthmatic Agents/therapeutic use ; Anti-Asthmatic Agents/administration & dosage ; Aged ; Formoterol Fumarate/administration & dosage ; Treatment Outcome ; Nitric Oxide/analysis ; Nitric Oxide/metabolism ; Budesonide, Formoterol Fumarate Drug Combination/administration & dosage ; Budesonide, Formoterol Fumarate Drug Combination/therapeutic use ; Respiratory Function Tests ; Eosinophils/drug effects

المؤلفون: Mu XD; Department of Respiratory and Critical Care Medicine, Beijing Tsinghua Changgung Hospital of Tsinghua University, Beijing 102218, China., Li XM; Department of Respiratory Medicine, Beijing Yanhua Hospital, Beijing 102599, China., He XP; Department of Respiratory and Critical Care Medicine, Xianyang Central Hospital, Xianyang 712000, China., Jia LH; Department of Pharmacy, Peking University International Hospital, Beijing 102206, China., Guan YH; Department of Respiratory and Critical Care Medicine, Department Ⅱ, the First Bethune Hospital of Jilin University, Jilin 130031, China., An FC; Department of Respiratory and Critical Care Medicine, Beijing Mentougou District Hospital, Beijing 102399, China., Chen LP; Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Shenyang Medical College, Shenyang 110000, China., Jia Q; Department of Respiratory Medicine, Beijing Longfu Hospital, Beijing 100010, China., Xiao AL; Department of Respiratory and Critical Care Medicine, General Hospital of Taigang Affiliated to Shanxi Medical University, Taiyuan 030008, China., Zhang LC; Department of Respiratory and Critical Care Medicine, Affiliated Zhongshan Hospital of Dalian University, Dalian 116000, China., Xiao ZH; Department of Respiratory and Critical Care Medicine, the Third People's Hospital of Datong, Datong 037046, China., Wang YM; Department of Respiratory Medicine, Hospital of Southern University of Science and Technology, Shenzhen 518000, China., Guan W; Department of Respiratory and Critical Care Medicine, Shenzhen Bao'an Central Hospital, Shenzhen 518000, China., Liu TT; GSK (Shanghai) R&D CO., LTD., Shanghai 201203, China., Su L; GSK (Shanghai) R&D CO., LTD., Shanghai 201203, China.

المصدر: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases [Zhonghua Jie He He Hu Xi Za Zhi] 2024 Jul 12; Vol. 47 (7), pp. 632-637.

نوع المنشور: Journal Article; Multicenter Study; Observational Study; English Abstract

بيانات الدورية: Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8712226 Publication Model: Print Cited Medium: Print ISSN: 1001-0939 (Print) Linking ISSN: 10010939 NLM ISO Abbreviation: Zhonghua Jie He He Hu Xi Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: Benzyl Alcohols*/administration & dosage , Benzyl Alcohols*/adverse effects , Chlorobenzenes*/adverse effects , Chlorobenzenes*/administration & dosage , Quinuclidines*/adverse effects , Quinuclidines*/administration & dosage, Humans ; Prospective Studies ; Aged ; Male ; Female ; China ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Middle Aged ; Asian People ; East Asian People

المؤلفون: Agusti A; Cátedra Salud Respiratoria, Universidad Barcelona, Institut Respiratori, Clinic Barcelona, FCRB-IDIBAPS, CIBERES, Spain. Electronic address: aagusti@clinic.cat., Lopez-Campos JL; Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Miravitlles M; Pneumology Department, Hospital Universitari Vall d'Hebron/Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Soler-Cataluña JJ; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Servicio de Neumología, Hospital Arnau de Vilanova-Lliria, Valencia, Spain; Departamento de Medicina, Universitat de València, Spain., Marin JM; Respiratory Service, Hospital Universitario Miguel Servet, IISAragón, Zaragoza, Spain., Cosio BG; Department of Respiratory Medicine, Hospital Universitario Son Espases-IdISBa, Universidad de las Islas Baleares, CIBERES, Spain., Alcázar-Navarrete B; Servicio de Neumología, Hospital Universitario Virgen de las Nieves, IBS-Granada, Universidad de Granada, CIBERES, Spain., Echave-Sustaeta JM; Pulmonary Department, Hospital Universitario Quironsalud Madrid, Universidad Europea de Madrid, Spain., Casanova C; Pulmonary Department - Research Unit, Hospital Universitario Nuestra Señora de La Candelaria, CIBERES, ISCIII, Universidad de La Laguna, Santa Cruz de Tenerife, Spain., Peces-Barba G; Pulmonology Department, IIS Fundación Jiménez Díaz, CIBERES, Spain., de-Torres JP; Pulmonary Department, Clinica Universidad de Navarra, IdisNa, Spain., Fernandez-Villar A; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Servicio de Neumología, Hospital Álvaro Cunqueiro, Instituto de Investigación Sanitaria Galicia Sur, Vigo, Spain., Ancochea J; Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, CIBER Enfermedades Respiratorias, Madrid, Spain., Villar-Alvarez F; Pulmonology Department, IIS Fundación Jiménez Díaz, Universidad Autónoma of Madrid, CIBER Enfermedades Respiratorias, Madrid, Spain., Roman-Rodriguez M; Primary Care Health Service Mallorca, Instituto de Investigación Sanitaria de las Islas Baleares (IdISBa) Palma, Universidad de las Islas Baleares, Spain., Molina J; Centro de Salud Francia, Fuenlabrada, Madrid, Spain; Dirección Asistencial Oeste, Spain., Garcia-Rivero JL; Respiratory Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Gonzalez C; Respiratory Department, Hospital Clínico Universitario, Valencia, Spain., Sobradillo P; Pulmonology Department, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain., Faner R; Biomedicine Department, University of Barcelona, FCRB-IDIBAPS, CIBERES, Barcelona, Spain., Peña C; GSK, Madrid, Spain., Sharma R; GSK, London, UK., Izquierdo JL; Department of Medicine and Medical Specialties, Universidad de Alcalá, Alcalá de Henares, Madrid, Respiratory Medicine, Hospital Universitario de Guadalajara, Guadalajara, Spain., Celli BR; Harvard Medical School, Boston, USA.

المصدر: Archivos de bronconeumologia [Arch Bronconeumol] 2024 Jul; Vol. 60 (7), pp. 417-422. Date of Electronic Publication: 2024 Apr 25.

نوع المنشور: Journal Article; Multicenter Study; Pragmatic Clinical Trial

بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0354720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1579-2129 (Electronic) Linking ISSN: 03002896 NLM ISO Abbreviation: Arch Bronconeumol Subsets: MEDLINE

مواضيع طبية MeSH: Benzyl Alcohols*/therapeutic use , Benzyl Alcohols*/administration & dosage , Drug Combinations* , Pulmonary Disease, Chronic Obstructive*/drug therapy, Female ; Humans ; Male ; Middle Aged ; Administration, Inhalation ; Adrenal Cortex Hormones/therapeutic use ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Adrenergic beta-2 Receptor Agonists/administration & dosage ; Androstadienes/therapeutic use ; Androstadienes/administration & dosage ; Bronchodilator Agents/therapeutic use ; Bronchodilator Agents/administration & dosage ; Chlorobenzenes/therapeutic use ; Chlorobenzenes/administration & dosage ; Drug Therapy, Combination ; Eosinophils ; Muscarinic Antagonists/therapeutic use ; Muscarinic Antagonists/administration & dosage ; Prospective Studies ; Quinuclidines/therapeutic use ; Quinuclidines/administration & dosage ; Treatment Outcome

المؤلفون: Hrabalová V; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkynova 118, Brno 612 00, Czech Republic., Opial T; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkynova 118, Brno 612 00, Czech Republic., Musilová J; Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, Technicka 12, Brno 616 00, Czech Republic., Sedlář K; Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, Technicka 12, Brno 616 00, Czech Republic., Obruča S; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkynova 118, Brno 612 00, Czech Republic. Electronic address: obruca@fch.vut.cz.

المصدر: Enzyme and microbial technology [Enzyme Microb Technol] 2024 Sep; Vol. 179, pp. 110475. Date of Electronic Publication: 2024 Jun 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8003761 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0909 (Electronic) Linking ISSN: 01410229 NLM ISO Abbreviation: Enzyme Microb Technol Subsets: MEDLINE

مواضيع طبية MeSH: Coumaric Acids*/metabolism , Vanillic Acid*/metabolism , Biotransformation* , Benzyl Alcohols*/metabolism, Industrial Microbiology

المؤلفون: Zhao M; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Zhou Y; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Sheng R; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Zhang H; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Xiang J; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Wang J; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Li P; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Ma T; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Liu P; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Chen Q; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China., Wen W; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China. Electronic address: wen_cdu@163.com., Xu S; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, 611137, PR China; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China; Institute of Material Medica Integration and Transformation for Brain Disorders, Chengdu University traditional Chinese medicine, Chengdu, 611137, PR China. Electronic address: xushijun@cdutcm.edu.cn.

المصدر: Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2024 Sep; Vol. 132, pp. 155819. Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Urban & Fischer Verlag Country of Publication: Germany NLM ID: 9438794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-095X (Electronic) Linking ISSN: 09447113 NLM ISO Abbreviation: Phytomedicine Subsets: MEDLINE

مواضيع طبية MeSH: Benzyl Alcohols*/pharmacology , Vesicular Monoamine Transport Proteins*/metabolism , Glucosides*/pharmacology , Dopamine*/metabolism , Mice, Inbred C57BL* , Homeostasis*/drug effects, Animals ; PC12 Cells ; Male ; Mice ; Rats ; Parkinson Disease/drug therapy ; Neuroprotective Agents/pharmacology ; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine ; Disease Models, Animal ; Molecular Docking Simulation ; Gastrodia/chemistry